In conclusion, we demonstrated that Plk1 inhibition leads to apoptosis in mesenchymal NSCLC owing to direct effects on Plk1, as well as parallel vimentin and β1‐integrin–mediated, ligand‐independent inhibition of cMet. The gene discussed is MET; the disease is non-small cell lung carcinoma.